Opportunities for the use of fatty acids of erythrocytes membranes and blood serum for diagnosis of Crown's disease

Aim of work is to study the features of the fatty acid (FA) composition of the membranes of erythrocytes (Er) and blood serum (BS) in patients with Crohn’s disease (CD) for possible use for diff erential diagnosis. Materials and methods . Using a gas chromatography-mass spectrometric system (GC/MS) based on three Agilent 7000B quadrupoles (USA), the composition of erythrocytes (Er) and blood serum (SC) of 60 people was studied: 19 — with Crohn’s disease (CD, 34±6,2 years), 21 — with unclassifi ed colitis (UCC, 35,2±4,7 years) and 20 healthy individuals (32,9±5,7 years). Results . It was found that the levels of most saturated, monounsaturated omega-9, omega-6 PUFAs were signifi cantly higher, and the content of the predominant part of omega-3, a number of omega-6 (linoleic, eicosadienoic, arachidonic) was lower than in healthy individuals. The relative content of FA in patients with unclassifi ed colitis turned out to be inter-mediate between those in patients with CD and healthy (p <0,0001–0,02). The obtained diff erentiating values of FA levels and their indices in the erythrocyte membranes made it possible to identify patients with suspected Crohn’s disease from those who were diagnosed with unclassifi ed colitis, which indicates the high potential of this approach for diff erential diagnosis. Conclusion . The created diagnostic panels (FA of blood serum and erythrocyte membranes) made it possible to diff erenti-ate patients with CD from healthy individuals with fairly high levels of sensitivity and specifi city. The revealed features of the levels of FA membranes of Er and BS, as well as their ratio in patients with CD, are promising for the purposes of diff erential diagnosis, including in cases of unclassifi ed colitis.

[1]  Yu. P. Uspenskiy,et al.  Патогенетические механизмы формирования анемического синдрома у пациентов с воспалительными заболеваниями кишечника , 2021 .

[2]  N. Hockstein,et al.  Fatty acid transporter 2 reprograms neutrophils in cancer , 2019, Nature.

[3]  V. Kruchinin,et al.  FEATURES OF FATTY ACIDS COMPOSITION OF BLOOD SERUM AND ERYTHROCYTE MEMBRANES IN PATIENTS WITH INFLAMMATORY INTESTINAL DISEASES (PILOT STUDY) , 2019, Современные проблемы науки и образования (Modern Problems of Science and Education).

[4]  V. Kruchinin,et al.  STUDY OF THE LEVEL OF FATTY ACIDS IN ERYTHROCYTE MEMBRANES AND SERUM OF PATIENTS WITH COLORECTAL CANCER IN NOVOSIBIRSK , 2018, Advances in molecular oncology.

[5]  William Stillwell,et al.  An Introduction to Biological Membranes : Composition, Structure and Function Ed. 2 , 2016 .

[6]  William Stillwell,et al.  Chapter 1 – Introduction to Biological Membranes , 2016 .

[7]  Е. С. Столяревич,et al.  ПОЗДНЯЯ ДИСФУНКЦИЯ ТРАНСПЛАНТИРОВАННОЙ ПОЧКИ: ПРИЧИНЫ, МОРФОЛОГИЧЕСКАЯ ХАРАКТЕРИСТИКА, ПОДХОДЫ К ПРОФИЛАКТИКЕ И ЛЕЧЕНИЮ , 2014 .

[8]  P. Munkholm,et al.  Inflammatory bowel disease epidemiology , 2013, Current opinion in gastroenterology.

[9]  H. Tajiri,et al.  The Fatty Acid Profile of the Erythrocyte Membrane in Initial-Onset Inflammatory Bowel Disease Patients , 2013, Digestive Diseases and Sciences.

[10]  Zhangsheng Yu,et al.  Low Blood Levels of Long-Chain n–3 Polyunsaturated Fatty Acids in US Hemodialysis Patients: Clinical Implications , 2012, American Journal of Nephrology.

[11]  K. Moore,et al.  Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. , 2010, Cell metabolism.

[12]  S. Culine,et al.  Abrogation of De novo Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice , 2010, Molecular Cancer Therapeutics.

[13]  V. Saraswathi,et al.  Inhibition of Long-Chain Acyl Coenzyme A Synthetases During Fatty Acid Loading Induces Lipotoxicity in Macrophages , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[14]  E. Riboli,et al.  Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case–control study within a European prospective cohort study , 2009, Gut.

[15]  B. Fielding,et al.  Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.

[16]  M. Wang,et al.  n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines. , 2008, Molecular immunology.

[17]  T. Bayless,et al.  Dietary antigens as aggravating factors in Crohn's disease , 1989, Digestive Diseases and Sciences.

[18]  A. Bousvaros,et al.  Serologic Testing with ANCA, ASCA, and Anti-OmpC in Children and Young Adults with Crohn's Disease and Ulcerative Colitis: Diagnostic Value and Correlation with Disease Phenotype , 2004, The American Journal of Gastroenterology.

[19]  L. Arab,et al.  Biomarkers and the measurement of fatty acids , 2002, Public Health Nutrition.

[20]  R. P. Thompson,et al.  Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. , 2000, Journal of autoimmunity.

[21]  S. Kitamura,et al.  Eicosapentaenoic acid modulates arachidonic acid metabolism in rat alveolar macrophages activated by silica. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  Sartor Rb Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. , 1997 .

[23]  Deventer,et al.  Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation. , 1996, Gut.

[24]  J. Guilland,et al.  Fatty acid composition of serum lipids and its relation to diet in an elderly institutionalized population. , 1988, The American journal of clinical nutrition.

[25]  W. Stenson,et al.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. , 1984, Gastroenterology.

[26]  I. Leodolter [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.